2025 updates and future research As of March 28, 2025, heres whats new with weight loss medications including tirzepatide
Similar content being viewed by others Introduction Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease globally 1,2
Call Ageless U or text us at (386) 747-1437 to book your weight loss consultation and take the first step toward achieving sustainable weight loss.
Hydration is key and can help prevent nausea, constipation, and dehydration
Semaglutide improves several lipid (blood fat) markers, including triglycerides and non-HDL cholesterol, through weight loss and direct effects like improved blood sugar levels
Because it could harm the unborn child, pregnant women should avoid it